IL15 and mesothelioma: Several lines of evidence suggest that NK cells may play a role in the tumor microenvironment, with asbestos inhibiting the cytolytic activity of NK cells and some data indicating that IL-15 in combination with an anti-PDL-1 antibody may be effective in re-activating NK cells against mesothelioma.